Manish Jain, President, Cilicant, shares insight on industry trends, particularly in active packaging solutions.

How early risk identification, standardized processes and digital technologies can help sponsors streamline technology ...

Understanding a CDMOs operating model under uncertainty can help determine whether it is the right partner for the program.

Brenton Saba is Vice President of Business Development at NewAtom Labs, where he leads commercial strategy and growth across North and South America. He develops strategic partnerships and works with ...

For high-dose, high-concentration biologics, early alignment preserves flexibility, exposes risks before they become expensive and avoids constraints in manufacturing, clinical de ...

Tony Bedford is a Commercial Director, Platform Management & Innovation at Phillips Medisize and has been involved in the design and development of medical devices for over 25 years. Prior to joining ...

Diversifying API sourcing and building qualified alternatives can help manufacturers reduce exposure to geographic ...

Technology transfer creates plenty of documentation. Process descriptions, risk assessments, batch records, specifications, ...

Agile CDMO partnerships can preserve scientific knowledge, reduce handoff risk and help programs move more smoothly from ...

Earlier alignment on trial design, evidence generation and geography can help emerging biopharma companies navigate ...

Stage-appropriate development can help lean biotech teams preserve capital, manage risk and maintain momentum without closing ...

Mike Stenberg, VP, Business Development, LGM Pharma, discusses LGM's strategic expansion, lessons learned from previous ...